*By Chloe Aiello* Warren Bravo thinks investors will get behind his fish waste-based cannabis concept when his company, Canadian marijuana producer Green Relief, heads to the public market this year. "We are going out, we'll say, sometime this year into the IPO space," Bravo, Green Relief CEO and co-founder, told Cheddar on Wednesday, adding that he's not committed to a specific time frame. "We want to make sure the market conditions are right, because we only have one chance to do that successfully and we want to make sure Green Relief tells the story investors want to hear." The story that Bravo is talking about concerns cannabis and fish ー or, more specifically, fish excrement. Green Relief has developed a system in which filtered fish waste is used to fertilize cannabis plants, which in turn, clean the water for the fish. It's a closed loop, recirculating ecosystem that enables pesticide-free farming. "It's the same ecosystem as any freshwater lake," Bravo said. "Any vegetation that grows in water is fertilized by the fish that live in that body of water. So we've commercialized an ecosystem, and made it scale-able and growing our cannabis plants in a very natural, clean, and organic way." Once the fish are no longer of use to the cannabis plants, Green Relief donates them to charity ー Bravo said the company has managed to provide as many as 50,000 meals to homeless shelters in the Toronto area. In the future, Bravo said Green Relief may consider monetizing the aquaculture portion of its business, and experimenting with using more valuable fish, like Asian sea bass, fresh water prawn, or koi to clean the water. But for now, Green Relief is sticking to tilapia. "Right now tilapia is what we do, because it's tried, proven and works really well in a farmed environment. So, as they say, 'if it ain't broke don't fix it,' and that's what we are using now," Bravo said. Bravo added that the company is "on the path to profitability," as it considers a public listing, and is currently working with lawyers to finalize its prospectus. For full interview [click here](https://cheddar.com/videos/cannabis-and-tilapia-make-for-unlikely-but-sustainable-pairing).

Share:
More In Business
TC BioPharm Goes Public, Looks to Future of Cancer, COVID-19 Cell Therapies
TC BioPharm, a biopharmaceutical company focused on developing cell therapy products targeting, went public on the Nasdaq in January. CEO Bryan Kobel joined Cheddar to talk about the company's IPO launch, its cancer-fighting therapeutics tech, and its potential for using its research to treat COVID-19. "The opportunity here for us is to really get safety data and covid and expand into other areas," Kobel said. "So from COVID, where we hope to treat patients, hopefully maybe the elderly population, populations that that really can't handle the antivirals because they're too hard in the system, well then we'll expand out into maybe severe influenza Ebola, other viral and viral infections where we think we can be helpful."
A Closer Look at the Gaming Sector and its Future in the Metaverse
The gaming industry has been under the spotlight so far this year following some big mergers and acquisitions. This week featured earnings of three major gaming companies, but also Meta and for the latter, things are not doing too hot. Joining Cheddar News to break it all down was Kenny Rosenblatt, President and Co-Founder of Arkadium.
Economy Appears to Be Back on Track in 2022 With Job Growth
Following the surprising big beat on estimates for the January jobs report, William M. Rodgers III, vice president and director of the Institute for Economic Equity at the Federal Reserve Bank of St. Louis, joined Cheddar News to break down the data. “We ended 2021 with a strong crescendo to a recovery that had taken hold, and we started 2022 in good fashion." He also discussed the dueling pressures of wage growth and inflation.
Load More